Arrowhead Pharmaceuticals, Inc. reported earnings results for the first quarter ended December 31, 2021. For the first quarter, the company reported sales was USD 27.44 million compared to USD 21.3 million a year ago. Net loss was USD 62.87 million compared to USD 20.73 million a year ago.

Basic loss per share from continuing operations was USD 0.6 compared to USD 0.2 a year ago. Diluted loss per share from continuing operations was USD 0.6 compared to USD 0.2 a year ago.